Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On July 9, 2024, before market open, Helen of Troy announced 1Q25 financial results and then reduced its revenue guidance for the 2Q and full fiscal year 2025. In pertinent part, the Company told investors that the “macro environment and the health of consumers and retailers has worsened,” causing the volume of sales to decline. Analysts questioned management over their visibility into earnings and potential problems in the future.
Helen of Troy’s stock price opened at $62.00 per share compared to $89.04 per share at close on June 8, 2024.
| Ticker Symbol | Company Name | Join Deadline | Join |
|---|---|---|---|
| SUI | Sun Communities, Inc. | February 10, 2025 | Join |
| SAVA | Cassava Sciences, Inc. | February 10, 2025 | Join |
| APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
| BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
| PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
| NVO | Novo Nordisk A/S | March 25, 2025 | Join |
| GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
| NEM | Newmont Corporation | April 01, 2025 | Join |